Columbia Sportswear Company (COLM) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Q2 2024 net sales declined 8% year-over-year to $570.2M, mainly due to lower U.S. wholesale sales amid soft consumer demand and retailer caution, partially offset by strong international growth, especially in China and Europe.
Q2 net loss was $11.8M (diluted EPS $(0.20)), compared to net income of $8.4M ($0.14 EPS) in Q2 2023.
Inventory was reduced by 29% year-over-year to $823.6M, and cash and short-term investments totaled $711.1M with no debt at quarter-end.
The Profit Improvement Program is on track to deliver $75–$90M in 2024 cost savings, with a multi-year target of $125–$150M annualized savings by 2026.
Operating cash flow for the first half was $108.9M, with a full-year target of over $350M.
Financial highlights
Q2 2024 net sales: $570.2M (down 8% year-over-year); Q2 gross margin: 47.9% (down 270 bps); Q2 operating margin: -4.2% (down from 1.0%).
SG&A expenses decreased 3% year-over-year but rose as a percent of sales to 53.1%.
Net loss for Q2 2024 was $11.8M; YTD net income was $30.6M (down from $54.6M prior year).
Free cash flow for the first six months was $81.1M, up from $(13.1)M in 2023.
Q2 effective tax rate was 21.6%, impacted by non-recurring stock compensation expense.
Outlook and guidance
Full-year 2024 net sales expected at $3.35–$3.42B, a 4%–2% decline; diluted EPS guidance unchanged at $3.65–$4.05.
Gross margin for 2024 expected to expand 40–60 bps to 50.0%–50.2%; SG&A as a percent of sales to rise to 42%–43%; operating margin projected at 7.7%–8.4%.
Operating cash flow for 2024 projected at over $350M; capex planned at $60–$80M.
Q3 2024 net sales expected at $927–$959M (down 6%–3% YoY); diluted EPS $1.27–$1.43.
Early Spring 2025 order book suggests a return to growth, including in North America wholesale.
Latest events from Columbia Sportswear Company
- Q4 margin gains and international growth contrast with full-year decline; 2025 outlook positive.COLM
Q4 20248 Jul 2026 - Q1 sales up 1%, outlook withdrawn amid tariff uncertainty; strong cash, share buybacks.COLM
Q1 20258 Jul 2026 - Board elections, key proposals, and 2025 results highlighted modest growth and strategic shifts.COLM
AGM 202615 Jun 2026 - Q1 2026 sales held steady at $779M as innovation and digital growth drive long-term strategy.COLM
Investor presentation15 May 2026 - Flat Q1 sales, improved FY2026 outlook, and strong international growth offset U.S. softness.COLM
Q1 20267 May 2026 - 2025 delivered modest sales growth, strong global expansion, and robust financial discipline.COLM
Investor presentation30 Apr 2026 - 2026 annual meeting covers director elections, pay, stock plan, and proxy access, with Board opposition to proxy access.COLM
Proxy filing24 Apr 2026 - Key votes include board elections, auditor ratification, and a proxy access proposal.COLM
Proxy filing24 Apr 2026 - Q4 sales fell 2% but margin rose; 2026 outlook sees 1–3% growth and tariff pressure.COLM
Q4 20254 Feb 2026